HIV/AIDS remains one of the most pressing global health challenges, with significant impacts on individuals, communities, and societies worldwide. Human Immunodeficiency Virus (HIV) weakens the immune system, making individuals vulnerable to opportunistic infections and diseases. Acquired Immunodeficiency Syndrome (AIDS) represents the advanced stage of HIV infection, characterized by severe immunosuppression and the onset of life-threatening illnesses. Despite advances in treatment and prevention, HIV/AIDS continues to disproportionately affect marginalized populations, including LGBTQ+ individuals, people of color, and those living in resource-limited settings. Efforts to combat HIV/AIDS encompass a multifaceted approach, including widespread testing, access to antiretroviral therapy, education, and stigma reduction. While progress has been made, ongoing dedication and collaboration are essential to achieving the goal of ending the HIV/AIDS epidemic globally.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Mathematical modeling of COVID-19 dynamics in a West African context
Christabel Emaeyak James, University of Glasgow, United Kingdom
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan